Clinical Trials Directory

Trials / Completed

CompletedNCT00630734

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin

Genetic Predictors of Pharmacokinetic Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin: the Role of SLCO1B1 Polymorphisms.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
32 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Pravastatin (Pravachol) is approved by the Food and Drug Administration (FDA) and is used to treat high cholesterol. Darunavir (Prezista) and ritonavir (Norvir) are approved by the Food and Drug Administration (FDA) to treat HIV infection. When darunavir and ritonavir are given with pravastatin, they can increase the blood levels of pravastatin. The degree of this interaction varies from person to person. The way that darunavir and ritonavir interact with pravastatin may be affected by a person's genetic make-up. Genetic factors (or DNA) are those that people are born with and that make each person unique. Genetic differences are the reason why one person's body traits such as height and hair color are different from another person's body traits. Genetic differences can also affect the way a medication works in the body or the way two medications interact in the body. The purpose of this clinical study is to determine if a person's genetic make-up affects the way darunavir and ritonavir interact with pravastatin in the body.

Conditions

Interventions

TypeNameDescription
DRUGPravastatinPravastatin 40 mg by mouth daily on days 1-4
DRUGDarunavirDarunavir 600mg by mouth twice daily on days 12-18
DRUGRitonavirRitonavir 100mg by mouth twice daily on days 12-18
DRUGPravastatinPravastatin 40 mg by mouth daily on days 15-18
OTHERWashoutWashout (no medication) on days 5-11.

Timeline

Start date
2008-02-01
Primary completion
2009-10-01
Completion
2010-09-01
First posted
2008-03-07
Last updated
2014-05-22
Results posted
2012-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00630734. Inclusion in this directory is not an endorsement.